Recall Atlas

Slate Run Pharmaceuticals recalls

2 official recalls and safety alerts involving Slate Run Pharmaceuticals since 2025-03, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Slate Run Pharmaceuticals or the relevant agency.

  1. 2026-03-04
  2. US
    Drugs & medicalClass III

    Slate Run Pharmaceuticals recalls Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous Use Only, Rx…

    Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.

    FDA · DrugSlate Run PharmaceuticalsNationwide within the USA.Official notice →
  3. 2025-03-26
  4. US
    Drugs & medicalClass II

    Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by:…

    CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

    FDA · DrugSlate Run PharmaceuticalsProduct was distributed to 8 distributors who may have further distribute the…Official notice →